0001225208-12-010131.txt : 20120424
0001225208-12-010131.hdr.sgml : 20120424
20120424180540
ACCESSION NUMBER: 0001225208-12-010131
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120424
FILED AS OF DATE: 20120424
DATE AS OF CHANGE: 20120424
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOWLIN MICHAEL R
CENTRAL INDEX KEY: 0001192506
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15525
FILM NUMBER: 12777094
MAIL ADDRESS:
STREET 1: 4800 ZION HILL ROAD
CITY: WEATHERFORD
STATE: TX
ZIP: 76088
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edwards Lifesciences Corp
CENTRAL INDEX KEY: 0001099800
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 364316614
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
BUSINESS PHONE: 9492502500
MAIL ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP.
DATE OF NAME CHANGE: 20090225
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP
DATE OF NAME CHANGE: 20000203
FORMER COMPANY:
FORMER CONFORMED NAME: CVG CONTROLLED INC
DATE OF NAME CHANGE: 19991126
4
1
doc4.xml
X0305
4
2012-04-24
0001099800
Edwards Lifesciences Corp
EW
0001192506
BOWLIN MICHAEL R
ONE EDWARDS WAY
IRVINE
CA
92614
1
Common Stock
2012-04-24
4
M
0
20000.0000
12.8850
A
92027.0000
D
Common Stock
2012-04-24
4
S
0
20000.0000
73.4300
D
72027.0000
D
Director Stock Option (Right to Acquire)
12.8850
2012-04-24
4
M
0
20000.0000
0.0000
D
2003-05-09
2012-05-08
Common Stock
20000.0000
0.0000
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2012.
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
This transaction was executed in multiple trades at prices ranging from $73.04 to $73.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Denise E. Botticelli, Attorney-in-Fact
2012-04-24